Prof. Dr. Markus Neurath

Lehrstuhl für Innere Medizin I (Medizin 1)

Mild COVID-19 Symptoms in an Infliximab-Treated Ulcerative Colitis Patient: Can Ongoing Anti-TNF Therapy Protect against the Viral Hyperinflammatory Response and Avoid Aggravated Outcomes? (2020) Abdullah A, Neurath M, Atreya R Journal article Covid-19 and immunomodulation in IBD (2020) Neurath M Journal article, Review article COVID-19: risk for cytokine targeting in chronic inflammatory diseases? (2020) Schett G, Sticherling M, Neurath M Journal article An IFN-STAT1-MLKL axis drives programmed necrosis of Paneth cells in Crohn's ileitis (2020) Hartmann L, Siegmund B, Weidinger C, Becker C, Neurath M, Günther C Conference contribution Efficacy, safety, and pharmacokinetics after switching from infliximab originator to biosimilar SB2 in inflammatory bowel disease patients: A long-term observational, prospective cohort study (2020) Fischer S, Mesfin SE, Klenske E, Schmitt H, Vitali F, Hirschmann S, Ramming A, et al. Conference contribution Dose-dependent differential effects of vedolizumab therapy on adhesion of regulatory and effector T cells (2020) Becker E, Wiendl M, Schulz-Kuhnt A, Atreya I, Atreya R, Neurath M, Zundler S Conference contribution Use of Fluorescent Dyes in Endoscopy and Diagnostic Investigation (2020) Hoffman A, Atreya R, Rath T, Neurath M Journal article, Review article Nanoparticles in Gastrooncology (2020) Jefremow A, Neurath M Journal article, Review article Immune Cell Circuits in Mucosal Wound Healing: Clinical Implications (2020) Zundler S, Tauschek V, Neurath M Journal article, Review article Correction to: Influence of cancer and acute inflammatory disease on taste perception: a clinical pilot study (Supportive Care in Cancer, (2019), 27, 4, (1579), 10.1007/s00520-019-4642-6) (2020) Schalk P, Kohl M, Herrmann HJ, Schwappacher R, Rimmele M, Büttner A, Neurath M, et al. Journal article, Erratum